Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Glick

Showing results (61-70 of 195) with videos related to

Pageof 20
Sort By:
The Johns Hopkins Medical Journal|January 1, 1975
Aortic dissection fifteen years after surgical repair of aortic coarctationT M Wray, D L Page, A Glick, et al.
The American Journal of Psychiatry|December 8, 2006
Clinical trial-based cost-effectiveness analyses of antipsychotic useDaniel Polsky, Jalpa A Doshi, Mark S Bauer, et al.
Pediatric Dermatology|September 23, 2016
Genetic Testing in Dermatology: A Survey Analyzing Obstacles to Appropriate CareDevorah R Shagalov, Georgina M Ferzli, Temima Wildman, et al.
Dermatology Online Journal|February 23, 2018
A pediatric case of unusual melanocytic proliferation of the nailRegine J Mathieu, Marjon Vatanchi, Edward R Heilman, et al.
Archives of Pediatrics & Adolescent Medicine|February 13, 1999
Clinical and economic impact of a combination Haemophilus influenzae and Hepatitis B vaccine: estimating cost-effectiveness using decision analysisA M Fendrick, J H Lee, C LaBarge, et al.
Journal of the American College of Cardiology|February 7, 2006
The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: a cost-effectiveness analysisRuchira Glaser, Henry A Glick, Howard C Herrmann, et al.
JAMA|December 25, 1991
Cost-effectiveness of HA-1A monoclonal antibody for gram-negative sepsis. Economic assessment of a new therapeutic agentK A Schulman, H A Glick, H Rubin, et al.
Pharmacoeconomics|February 7, 1995
Relationships between sponsors and investigators in pharmacoeconomic and clinical researchK A Schulman, L E Rubenstein, H A Glick, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1995
Introduction to clinical economics: assessment of cancer therapiesK A Schulman, H A Glick, K R Yabroff, et al.
International Journal of Technology Assessment in Health Care|October 24, 2002
Effects of linezolid on hospital length of stay compared with vancomycin in treatment of methicillin-resistant Staphylococcus infections. An application of multivariate survival analysisRichard J Willke, Henry A Glick, Jim Z Li, et al.
Pageof 20

Showing results (61-70 of 195) with videos related to

Sort By:
Pageof 20
The Johns Hopkins Medical Journal|January 1, 1975
Aortic dissection fifteen years after surgical repair of aortic coarctationT M Wray, D L Page, A Glick, et al.
The American Journal of Psychiatry|December 8, 2006
Clinical trial-based cost-effectiveness analyses of antipsychotic useDaniel Polsky, Jalpa A Doshi, Mark S Bauer, et al.
Pediatric Dermatology|September 23, 2016
Genetic Testing in Dermatology: A Survey Analyzing Obstacles to Appropriate CareDevorah R Shagalov, Georgina M Ferzli, Temima Wildman, et al.
Dermatology Online Journal|February 23, 2018
A pediatric case of unusual melanocytic proliferation of the nailRegine J Mathieu, Marjon Vatanchi, Edward R Heilman, et al.
Archives of Pediatrics & Adolescent Medicine|February 13, 1999
Clinical and economic impact of a combination Haemophilus influenzae and Hepatitis B vaccine: estimating cost-effectiveness using decision analysisA M Fendrick, J H Lee, C LaBarge, et al.
Journal of the American College of Cardiology|February 7, 2006
The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: a cost-effectiveness analysisRuchira Glaser, Henry A Glick, Howard C Herrmann, et al.
JAMA|December 25, 1991
Cost-effectiveness of HA-1A monoclonal antibody for gram-negative sepsis. Economic assessment of a new therapeutic agentK A Schulman, H A Glick, H Rubin, et al.
Pharmacoeconomics|February 7, 1995
Relationships between sponsors and investigators in pharmacoeconomic and clinical researchK A Schulman, L E Rubenstein, H A Glick, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1995
Introduction to clinical economics: assessment of cancer therapiesK A Schulman, H A Glick, K R Yabroff, et al.
International Journal of Technology Assessment in Health Care|October 24, 2002
Effects of linezolid on hospital length of stay compared with vancomycin in treatment of methicillin-resistant Staphylococcus infections. An application of multivariate survival analysisRichard J Willke, Henry A Glick, Jim Z Li, et al.
Pageof 20